Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Repligen identifies angiogenic growth factor inhibitors

July 29, 1997

Targeted Genetics cancer gene therapy product approved for European clinical trials

July 28, 1997

Allos Therapeutics reports clinical results of RSR13

July 28, 1997

Known heart failure drug studied for AML

July 28, 1997

Sparta's oral chemotherapeutic agent enters clinical trials

July 25, 1997

Cambridge NeuroScience awarded SBIR grant for cancer research

July 25, 1997

Asta prepares and evaluates targeted cytotoxic anthracycline analogues

July 24, 1997

Ansan announces merger with Discovery Laboratories and licensing agreement with Titan

July 24, 1997

IDEC acquires anticancer agent from Pharmacia & Upjohn

July 23, 1997

Emitefur: phase II results in breast, gastric and pancreatic cancer

July 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...